Waltham, Massachusetts – (The Hosting News) – July 17, 2006 – Data management solutions firm, Phase Forward Incorporated, will release financial results for the quarter ended June 30, 2006 and hold a conference call with investors on Thursday, July 27, 2006 at 5:00 p.m. (EST).
Bob Weiler, President and Chief Executive Officer, and Rodger Weismann, Senior Vice President and Chief Financial Officer, will host the investor conference call, to discuss second quarter financial results and the company’s outlook for the third quarter and remainder of 2006.
To participate by telephone, the domestic dial-in number is 800-320-2978 and the international dial-in is 617-614-4923. The access code is 14026974. Investors are advised to dial-in at least five minutes prior to the call to register.
Phase Forward is a provider of integrated data management solutions for clinical trials and drug safety. The company offers solutions for electronic data capture, clinical management, clinical trials signal detection, strategic pharmacovigilance and Signal Management, adverse event reporting and applied data standards. In addition, the company provides services in the areas of application implementation, hosting and validation, data integration, business process optimization, safety data management and industry standards. Phase Forward’s products and services have been utilized in over 10,000 clinical trials involving more than 1,000,000 clinical trial study participants at over 230 organizations and regulatory agencies worldwide including: AstraZeneca, Biogen Idec, Boston Scientific, Dana-Farber Cancer Institute, Eli Lilly, Food and Drug Administration, GlaxoSmithKline, Guidant, Merck, U.K. Medicines and Healthcare Products Regulatory Agency, National Institutes of Health, Procter and Gamble, Quintiles, sanofi-aventis, Schering-Plough Research Institute and Serono.
To learn more about the investor conference call, please visit ”Investors” tab at: www.phaseforward.com.
For more information about Phase Forward, please visit: www.phaseforward.com.